A 72-year-old woman with atrial fibrillation (not on anticoagulation) presents with acute onset left hemiparesis and hemisensory loss. Non-contrast CT head performed at 6 hours post-symptom onset shows no acute intracranial hemorrhage. MRI brain with DWI sequences shows acute ischemic changes in the right middle cerebral artery territory. However, 48 hours later, repeat imaging shows hyperdensity in the same region with mass effect and clinical deterioration. Which imaging modality is most appropriate to characterize this hemorrhagic transformation and assess for thrombus extension?

Explanation

## Imaging Hemorrhagic Transformation in Acute Ischemic Stroke ### Clinical Scenario Analysis This patient has acute ischemic stroke with subsequent hemorrhagic transformation (HT), a serious complication occurring in 10–40% of ischemic stroke cases. The clinical deterioration and imaging findings suggest both hemorrhage and possible thrombus extension, requiring comprehensive vascular and parenchymal assessment. ### Why MRI with SWI and MRA is Correct **Key Point:** MRI with susceptibility-weighted imaging (SWI) and MR angiography (MRA) is superior for characterizing hemorrhagic transformation and assessing vascular patency: - **SWI sequences** are exquisitely sensitive for blood products (hemosiderin, deoxyhemoglobin) and can differentiate hemorrhagic infarction from parenchymal hematoma - **MRA** provides high-resolution visualization of intracranial and extracranial vessels without contrast, detecting thrombus, dissection, or recanalization - **DWI/ADC** (already performed) confirm acute ischemia; repeat MRI adds vascular detail **High-Yield:** SWI is more sensitive than CT for detecting microhemorrhages and blood product evolution, and MRA avoids iodinated contrast (important in renal impairment or contrast allergy). ### Comparison of Imaging Modalities for Hemorrhagic Transformation | Modality | Hemorrhage Detection | Vascular Assessment | Contrast Required | Sensitivity for Microhemorrhage | |---|---|---|---|---| | **NCCT** | Good (acute hyperdensity) | Poor | No | Very low | | **CTP + CTA** | Moderate | Excellent (CTA) | Yes (iodinated) | Low | | **MRI + SWI + MRA** | Excellent (all phases) | Excellent (MRA) | No (MRA non-contrast) | **Highest** | | **Transcranial Doppler** | None | Bedside flow assessment only | No | N/A | **Clinical Pearl:** Hemorrhagic transformation is classified as: 1. **HI-1 / HI-2** (hemorrhagic infarction): small petechial hemorrhages within infarct 2. **PH-1 / PH-2** (parenchymal hematoma): >30% of infarct volume with mass effect SWI is the gold standard for detecting and grading these subtypes. ### Why MRI with SWI + MRA Surpasses Alternatives **Advantages over NCCT:** - NCCT is insensitive to microhemorrhages and cannot assess vessel patency - SWI detects blood products at all stages (acute, subacute, chronic) **Advantages over CTP + CTA:** - CTA is excellent for large vessel occlusion but requires iodinated contrast - CTP assesses perfusion but is less sensitive for hemorrhage characterization than SWI - MRA provides equivalent vascular detail without contrast **Advantages over Transcranial Doppler:** - TCD is bedside but cannot diagnose hemorrhage or visualize parenchyma - Operator-dependent; poor acoustic windows in elderly patients ### Diagnostic Pathway ```mermaid flowchart TD A["Acute ischemic stroke on MRI DWI"]:::outcome --> B["Thrombolysis/thrombectomy?"]:::decision B -->|"Yes"| C["CTA for LVO assessment"]:::action B -->|"No"| D["Monitor clinically"]:::action D --> E{"Clinical deterioration?"}:::decision E -->|"Yes"| F["Repeat imaging for HT"]:::action F --> G{"Characterize HT + assess vessels?"}:::decision G -->|"MRI SWI + MRA preferred"| H["Detect microhemorrhage, grade HT, assess recanalization"]:::action G -->|"NCCT only"| I["Limited hemorrhage detail, no vascular info"]:::outcome H --> J{"Thrombus extension or new occlusion?"}:::decision J -->|"Yes"| K["Neurology/Neurosurgery consult"]:::action ``` **Warning:** Do not rely on NCCT alone for hemorrhagic transformation assessment in the subacute phase; microhemorrhages and small petechial bleeds may be missed, leading to underestimation of HT severity. [cite:Harrison 21e Ch 296; Robbins 10e Ch 28]